syros.com - Multiplikator EV/Sales SYRS

Simbol resmi perusahaan Syros Pharmaceuticals Inc. (SYRS)

Syros Pharmaceuticals (SYRS) is developing a gene control system for the treatment of cardiac and oncological pathologies. This chart in the GURU.Markets terminal illustrates the company's enterprise value to revenue (EV/Revenue) valuation, where the indicator determines the metric's magnitude. This price action reflects the stable operation of production lines and a strategic partnership with medical centers to develop targeted drugs against leukemia.

Multiplikator EV/Sales Syros Pharmaceuticals, Inc. (SYRS): kanggo periode 04.07.2022 - 20.11.2026

Rincian metrik keuangan lan pasar Syros Pharmaceuticals, Inc. (SYRS)

Pambiji fundamental perusahaan:SYRS (Syros Pharmaceuticals)
Produk seri syros.com

Developing precision medicines for leukemia therapy requires colossal investments, which is why the market value of Syros Pharmaceuticals (SYRS) is often decoupled from current earnings. This indicator compares the total enterprise value to revenue, excluding the impact of debt and leverage, allowing for an objective assessment of asset overvaluation and the risk of capital freeze through changes in the company's enterprise value-to-revenue multiple.

Analisis pesaing Syros Pharmaceuticals

TEM (tempus.com) - Rasio nilai perusahaan marang pendapatan|qiagen.com (QGEN) - Rasio nilai perusahaan marang pendapatan|Ionis (IONS) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Repligen|Avidity (RNA) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales CRSP|Rasio total nilai perusahaan marang pendapatan GeneDx|Rasio nilai perusahaan marang pendapatan Ultragenyx RARE|Rasio total nilai perusahaan marang pendapatan Beam Therapeutics (BEAM)|SRPT: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Twist Bioscience|TXG (10x Genomics) - Nilai perusahaan marang pendapatan|Intellia Therapeutics, Inc. (NTLA) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Stoke Therapeutics Inc|BLFS: Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan WVE (Wave Life Sciences Corp)|Rasio total nilai perusahaan marang pendapatan Maze Therapeutics Corp|Sionna Therapeutics Inc - Nilai perusahaan marang pendapatan|PRME (primemedicine.com) - Nilai perusahaan marang volume dodolan|TSHA - Rasio nilai perusahaan marang pendapatan|QURE (uniQure) - Rasio nilai perusahaan marang pendapatan|MeiraGTx Corp (MGTX) - Rasio nilai perusahaan marang pendapatan|Regenxbio - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan solidbio.com|Multiplikator nilai perusahaan marang pendapatan ocugen.com OCGN|Multiplikator EV/Sales PACB|Benitec - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Design Therapeutics DSGN|Multiplikator EV/Sales Rocket Pharmaceuticals RCKT|Nilai perusahaan marang volume dodolan 4D Molecular Corp|LXEO: Rasio nilai perusahaan marang pendapatan|KRRO (Korro Bio, Inc) - Nilai perusahaan marang pendapatan|Editas Medicine (EDIT) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Silence Therapeutics Inc.|Rasio nilai perusahaan marang pendapatan PRQR (proqr.com)|Rasio nilai perusahaan marang pendapatan Codexis Bio (CDXS)|Multiplikator EV/Sales sangamo.com (SGMO)|Rasio nilai perusahaan marang pendapatan nautilus.bio NAUT|Rasio total nilai perusahaan marang pendapatan Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Multiplikator EV/Sales|GBIO - Multiplikator EV/Sales|BOLD: Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan XCUR|Rasio nilai perusahaan marang pendapatan Imunon|Phio Pharmaceuticals - Nilai perusahaan marang volume dodolan|Rasio nilai perusahaan marang pendapatan Mustang Bio, Inc. (MBIO)|Rasio total nilai perusahaan marang pendapatan TransCode Therapeutics, Inc.|Rasio nilai perusahaan marang pendapatan Bionano Genomics BNGO|Nilai bisnis marang pendapatan APDN|BLUE - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang volume dodolan IPA|Omega Therapeutics, Inc. (OMGA) - Rasio nilai perusahaan marang pendapatan|Singular Genomics Corp (OMIC) - Multiplikator EV/Sales|RGLS (Regulus Therapeutics, Inc.) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan Telesis Bio (TBIO)|Multiplikator EV/Sales TCON|UBX - Multiplikator nilai perusahaan marang pendapatan